0001415889-23-013042.txt : 20230906 0001415889-23-013042.hdr.sgml : 20230906 20230906190600 ACCESSION NUMBER: 0001415889-23-013042 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230901 FILED AS OF DATE: 20230906 DATE AS OF CHANGE: 20230906 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Ragosa Mark CENTRAL INDEX KEY: 0001835458 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38492 FILM NUMBER: 231240621 MAIL ADDRESS: STREET 1: C/O KINIKSA PHARMACEUTICALS CORP. STREET 2: 100 HAYDEN AVENUE CITY: LEXINGTON STATE: MA ZIP: 02421 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Kiniksa Pharmaceuticals, Ltd. CENTRAL INDEX KEY: 0001730430 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: D0 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: CLARENDON HOUSE STREET 2: 2 CHURCH STREET CITY: HAMILTON STATE: D0 ZIP: HM11 BUSINESS PHONE: 7814399100 MAIL ADDRESS: STREET 1: CLARENDON HOUSE STREET 2: 2 CHURCH STREET CITY: HAMILTON STATE: D0 ZIP: HM11 4 1 form4-09062023_110953.xml X0508 4 2023-09-01 0001730430 Kiniksa Pharmaceuticals, Ltd. KNSA 0001835458 Ragosa Mark C/O KINIKSA PHARMACEUTICALS, LTD. CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM 11 BERMUDA false true false false CHIEF FINANCIAL OFFICER 0 Class A Common Share 2023-09-01 4 M 0 2695 A 15109 D Class A Common Share 2023-09-01 4 F 0 791 17.76 D 14318 D Class A Common Share 2023-09-02 4 M 0 1861 A 16179 D Class A Common Share 2023-09-02 4 F 0 547 17.76 D 15632 D Restricted Share Unit 2023-09-01 4 M 0 2695 0 D Class A Common Share 2695 8082 D Restricted Share Unit 2023-09-01 4 A 0 7000 0 A 2033-08-31 Class A Common Share 7000 7000 D Share Option 17.76 2023-09-01 4 A 0 42050 0 A Class A Common Share 42050 42050 D Restricted Share Unit 2023-09-02 4 M 0 1861 0 D Class A Common Share 1861 3722 D Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer. The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of the grant, September 1, 2022. The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of the grant, September 1, 2023. The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter. The vesting commencement date is September 1, 2023. The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of the grant, September 2, 2021. /s/ Madelyn Zeylikman, Attorney-in-Fact 2023-09-06